Endoscopic Devices - Brazil | Statista Market Forecast

In Brazil, revenue in the Endoscopic Devices market market is projected to reach US$562.40m in 2024.
It is expected that revenue will demonstrate an annual growth rate (CAGR 2024-2029) of 8.00%, culminating in a market volume of US$826.50m by 2029.
When compared globally, the highest revenue will be generated the United States, with a forecast of US$10.39bn in 2024.
Brazil is witnessing a surge in demand for advanced endoscopic devices, driven by an increasing emphasis on minimally invasive surgical techniques in its healthcare sector.

Definition:
The Endoscopic Devices market, a medical technology market, includes the sale of endoscopic devices. Endoscopy involves the use of an endoscope to examine the inside of a hollow organ or body cavity. The market includes various types of endoscopes, such as gastroscopes, laparoscopes, bronchoscopes, and colonoscopes.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Olympus Corporation, Boston Scientific Corporation, and Stryker Corporation. Further information on the key players can be found in the Market Shares boxes.

Endoscopic devices
Implants such as stents

pharmaceuticals for endoscopic procedure

The Endoscopic Devices Market in Brazil is witnessing moderate growth, influenced by factors such as increasing healthcare investments, advancements in minimally invasive procedures, and a growing emphasis on patient safety and recovery times within the medical technology sector.

Customer preferences: Consumers in Brazil are increasingly favoring minimally invasive surgical options, reflecting a cultural shift towards prioritizing quicker recovery and reduced hospital stays. This trend is influenced by demographic changes, such as an aging population seeking effective yet less invasive treatments. Additionally, younger generations are becoming more engaged in their healthcare decisions, emphasizing the importance of safety and efficacy in procedures. As awareness of endoscopic advancements grows, patients are more inclined to choose technologies that promise less pain and faster return to daily activities.

Trends in the market: In Brazil, the Endoscopic Devices Market is experiencing a significant shift towards advanced minimally invasive procedures, driven by an increasing demand for quicker recovery times and reduced hospital stays. This trend is fueled by the aging population, which is seeking effective treatment options with lower risks and complications. Additionally, younger patients are becoming more informed and proactive about their healthcare choices, prioritizing safety and efficacy. As awareness of endoscopic technologies rises, healthcare providers and manufacturers must adapt to these evolving preferences, potentially reshaping product development and marketing strategies to meet the growing demand for innovative, patient-centered solutions.

Local special circumstances: In Brazil, the Endoscopic Devices Market is shaped by a diverse healthcare landscape characterized by regional disparities in access to care and varying levels of technological adoption. The country's vast geography presents challenges in delivering specialized medical services, particularly in remote areas where traditional surgical options may not be feasible. Cultural attitudes towards health and wellness emphasize preventative care, prompting a shift towards minimally invasive procedures. Furthermore, regulatory frameworks are evolving, fostering innovation while ensuring patient safety, which influences the availability and adoption of advanced endoscopic technologies across the nation.

Underlying macroeconomic factors: The Endoscopic Devices Market in Brazil is significantly influenced by macroeconomic factors, including national economic stability, healthcare spending, and investment in medical technology. The country's economic health, characterized by fluctuating GDP growth rates and inflation, impacts public and private healthcare budgets, subsequently affecting the acquisition of advanced endoscopic devices. Additionally, government fiscal policies aimed at improving healthcare access and funding for innovation play a crucial role in market dynamics. Global economic trends, such as the increasing demand for minimally invasive procedures and advances in technology, further drive market growth, as Brazilian healthcare providers seek to enhance patient outcomes while managing costs effectively.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.